Ebola Vaccine Trial

An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.

A fresh clinical trial of a new Ebola vaccine has found that it is well tolerated, safe and stimulates strong immune responses in adults in Mali, West Africa and in the US.

A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, marking the vaccine's first overseas clinical trial permit.

A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.

An Ebola vaccine provided 100-percent protection in a field trial in hard-hit Guinea, researchers and officials said Friday, mooting "the beginning of the end" of the killer West African outbreak.

The first needle-free Ebola vaccine that can be inhaled protects non-human primates against the deadly virus and may advance to human clinical trials soon, scientists say.

Ghana has halted a plan to test two Ebola vaccines in an eastern town after legislators backed local protests against the trials sparked by fears of contamination, officials said on Wednesday.

An Indian-origin researcher has helped in identifying the kind of human trial that is most effective for testing Ebola vaccines so as to stop future outbreaks of the deadly virus.

Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.

Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.

Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said today.

A large-scale human trial of two potential Ebola vaccines got under way in Liberia's capital Monday, part of a global effort to prevent a repeat of the epidemic that has now claimed nearly 9,000 lives in West Africa.

A trial of an Ebola vaccine was to start Monday in Liberia's capital following a launch event featuring musicians.

Preliminary results from a clinical trial on an experimental Ebola vaccine developed by GlaxoSmithKline and the US National Institutes of Health suggest it is safe for use, researchers said on Wednesday.

Human tests of two possible Ebola vaccines have proven safe and now tests to measure their efficiency will begin within weeks in the three west African countries ravaged by the deadly virus, the World Health Organization said on Friday.

An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.

A fresh clinical trial of a new Ebola vaccine has found that it is well tolerated, safe and stimulates strong immune responses in adults in Mali, West Africa and in the US.

A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, marking the vaccine's first overseas clinical trial permit.

A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.

An Ebola vaccine provided 100-percent protection in a field trial in hard-hit Guinea, researchers and officials said Friday, mooting "the beginning of the end" of the killer West African outbreak.

The first needle-free Ebola vaccine that can be inhaled protects non-human primates against the deadly virus and may advance to human clinical trials soon, scientists say.

Ghana has halted a plan to test two Ebola vaccines in an eastern town after legislators backed local protests against the trials sparked by fears of contamination, officials said on Wednesday.

An Indian-origin researcher has helped in identifying the kind of human trial that is most effective for testing Ebola vaccines so as to stop future outbreaks of the deadly virus.

Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.

Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.

Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said today.

A large-scale human trial of two potential Ebola vaccines got under way in Liberia's capital Monday, part of a global effort to prevent a repeat of the epidemic that has now claimed nearly 9,000 lives in West Africa.

A trial of an Ebola vaccine was to start Monday in Liberia's capital following a launch event featuring musicians.

Preliminary results from a clinical trial on an experimental Ebola vaccine developed by GlaxoSmithKline and the US National Institutes of Health suggest it is safe for use, researchers said on Wednesday.

Human tests of two possible Ebola vaccines have proven safe and now tests to measure their efficiency will begin within weeks in the three west African countries ravaged by the deadly virus, the World Health Organization said on Friday.